Back to Search
ARLO MILLER, MD
MD
Dermatology Physician
NPI: 1407990161IndividualAccepts Medicare
Specialties, Licenses & Credentials
MOHS-Micrographic Surgery Physician
Dermatology — MOHS-Micrographic Surgery
Code: 207ND0101X
MD60173899(WA)
Dermatopathology Physician
Dermatology — Dermatopathology
Code: 207ND0900X
MD60173899(WA)
Procedural Dermatology Physician
Dermatology — Procedural Dermatology
Code: 207NS0135X
MD60173899(WA)
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
MD60173899(WA)
CMS Specialties
PrimaryDERMATOLOGY
Education
HARVARD MEDICAL SCHOOL
Class of 2006
Research & Publications (20)
Generation of a novel system for studying spleen tyrosine kinase function in macrophages and B cells.
PMID 19124742·J Immunol·2009
7-preclinical
Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301.
PMID 19255312·J Clin Oncol·2009
3-trial
Microglial cell migration stimulated by ATP and C5a involve distinct molecular mechanisms: quantification of migration by a novel near-infrared method.
PMID 19053059·Glia·2009
7-preclinical
Shellfish face uncertain future in high CO2 world: influence of acidification on oyster larvae calcification and growth in estuaries.
PMID 19478855·PLoS One·2009
7-preclinical
Pediatric cardiopulmonary bypass circuits: a review of studies conducted at the Penn State Pediatric Cardiac Research Laboratories.
PMID 19361042·J Extra Corpor Technol·2009
6-review
CB2 receptor-mediated migration of immune cells: it can go either way.
PMID 17982478·Br J Pharmacol·2008
6-review
Rapamycin does not improve insulin sensitivity despite elevated mammalian target of rapamycin complex 1 activity in muscles of ob/ob mice.
PMID 18768766·Am J Physiol Regul Integr Comp Physiol·2008
7-preclinical
Hyaluronidase 2 and its intriguing role as a cell-entry receptor for oncogenic sheep retroviruses.
PMID 18485731·Semin Cancer Biol·2008
6-review
Identification of the myelin protein plasmolipin as the cell entry receptor for Mus caroli endogenous retrovirus.
PMID 18463156·J Virol·2008
7-preclinical
Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303).
PMID 18827613·J Thorac Oncol·2008
3-trial
The Nanoparticle Information Library (NIL): a prototype for linking and sharing emerging data.
PMID 17924276·J Occup Environ Hyg·2007
8-other
Role of lubrication oil in particulate emissions from a hydrogen-powered internal combustion engine.
PMID 17969702·Environ Sci Technol·2007
8-other
Real-time estimation of elemental carbon emitted from a diesel engine.
PMID 17874787·Environ Sci Technol·2007
8-other
Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002.
PMID 17607121·J Thorac Oncol·2007
3-trial
Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101.
PMID 17634483·J Clin Oncol·2007
3-trial
Room temperature ionic liquids: new solvents for Schrock's catalyst and removal using polydimethylsiloxane membranes.
PMID 17713075·Chem Commun (Camb)·2007
8-other
Phase II study of carboplatin, irinotecan, and thalidomide in patients with advanced non-small cell lung cancer.
PMID 17409967·J Thorac Oncol·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 450 NW GILMAN BLVD, SUITE 301A
ISSAQUAH, WA 98027 - Phone
- (425) 654-1275
Quick Facts
- NPI
- 1407990161
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Years in Practice
- 20
- Publications
- 20
Are you this provider?
Claim Your Profile